Rigel Pharmaceuticals Inc SEC filings RIGL
Rigel Pharmaceuticals Inc has 1,002 filings in SEC EDGAR's recent list, going back to Nov 6, 2007. Its latest annual report, Form 10-K, was filed on Mar 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 4, 2026 | — |
| S-8 | Employee stock plan registration | Aug 6, 2025 | — |
| S-8 | Employee stock plan registration | Aug 6, 2024 | — |
| S-3 | Shelf registration | Aug 2, 2024 | — |
| S-8 | Employee stock plan registration | Aug 1, 2023 | — |
| S-8 | Employee stock plan registration | Mar 7, 2023 | — |
| S-8 | Employee stock plan registration | Aug 3, 2022 | — |
| S-8 | Employee stock plan registration | Mar 1, 2022 | — |
| POS AM | Filing | Mar 1, 2022 | — |
| S-3ASR | Automatic shelf registration | Aug 3, 2021 | — |
| S-8 | Employee stock plan registration | Jun 21, 2021 | — |
| S-8 | Employee stock plan registration | Aug 4, 2020 | — |
| 424B5 | Prospectus supplement | Aug 4, 2020 | — |
| S-8 | Employee stock plan registration | Aug 7, 2019 | — |
| S-8 | Employee stock plan registration | Aug 8, 2018 | — |
| 424B5 | Prospectus supplement | Apr 20, 2018 | — |
| 424B5 | Prospectus supplement | Apr 18, 2018 | — |
| S-3 | Shelf registration | Mar 9, 2018 | — |
| S-8 | Employee stock plan registration | Nov 7, 2017 | — |
| 424B5 | Prospectus supplement | Oct 5, 2017 | — |
| S-3MEF | Filing | Oct 4, 2017 | — |
| 424B5 | Prospectus supplement | Oct 3, 2017 | — |
| S-8 | Employee stock plan registration | Aug 1, 2017 | — |
| 424B5 | Prospectus supplement | May 30, 2017 | — |
| S-8 | Employee stock plan registration | Mar 7, 2017 | — |
| 424B5 | Prospectus supplement | Jan 31, 2017 | — |
| 424B5 | Prospectus supplement | Jan 30, 2017 | — |
| S-8 | Employee stock plan registration | Nov 1, 2016 | — |
| S-8 | Employee stock plan registration | Aug 3, 2016 | — |
| 424B5 | Prospectus supplement | Aug 18, 2015 | — |
| S-3 | Shelf registration | May 7, 2015 | — |
| S-8 | Employee stock plan registration | Jun 5, 2014 | — |
| S-8 | Employee stock plan registration | Jun 21, 2013 | — |
| 424B5 | Prospectus supplement | Oct 3, 2012 | — |
| 424B5 | Prospectus supplement | Oct 2, 2012 | — |
| S-8 | Employee stock plan registration | Aug 7, 2012 | — |
| S-3 | Shelf registration | Mar 8, 2012 | — |
| S-8 | Employee stock plan registration | Aug 2, 2011 | — |
| 424B5 | Prospectus supplement | May 26, 2011 | — |
| 424B5 | Prospectus supplement | May 25, 2011 | — |
| S-3MEF | Filing | May 25, 2011 | — |
| S-3 | Shelf registration | Dec 14, 2010 | — |
| S-8 | Employee stock plan registration | Aug 3, 2010 | — |
| 424B5 | Prospectus supplement | Sep 17, 2009 | — |
| FWP | Free writing prospectus | Sep 17, 2009 | — |
| S-3MEF | Filing | Sep 17, 2009 | — |
| 424B5 | Prospectus supplement | Sep 16, 2009 | — |
| POS AM | Post-effective amendment not automatically effective upon filing | Feb 27, 2009 | — |
| S-8 | Employee stock plan registration | Nov 4, 2008 | — |
| 424B5 | Prospectus supplement | Feb 1, 2008 | — |
| 424B3 | Prospectus | Jan 24, 2008 | — |
| S-3ASR | Automatic shelf registration | Jan 24, 2008 | — |
| S-8 | Employee stock plan registration | Dec 18, 2007 | — |
Showing 53 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RIGL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1034842
- Former names
- RIGEL PHARMACEUTICALS INC (until Nov 5, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.